Breaking News

ICON Gains MHRA Accreditation

ICON’s hospital-based Clinical Pharmacology Unit in Manchester, UK has achieved Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON’s hospital-based Clinical Pharmacology Unit in Manchester, UK has achieved Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA). The unit is part of the ICON Development Solutions division. The designation allows the company to carry out all Phase I trials, including First in Human (FIH) trials requiring review from the EAG (Expert Advisory Group). Thomas Frey, president of ICON Development Solutions, commented, “Our Clinical Pharmacology team ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters